Skip to content

Effectiveness of Repetitive Transcranial Magnetic Stimulation in Treating Urinary Disorders after Stroke

Effectiveness of Repetitive Transcranial Magnetic Stimulation in Treating Urinary Disorders after Stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042688
Enrollment
Unknown
Registered
2021-01-26
Start date
2021-01-26
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Dysuria

Interventions

Intervention group:rTMS+regular therapy

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for stroke (including cerebral hemorrhage and cerebral infarction) established by the 4th National Cerebrovascular Disease Conference in 1995, and confirmed by CT or MRI of the head, and the course of the disease is 1 to 12 months; 2. Clinical symptoms include frequent urination, urgency, and urinary incontinence; 3. The urination function was normal before the stroke, and the urination function was abnormal only after the stroke; 4. The age of the patient is >= 30 years old, and the gender is not limited; 5. No symptoms of progressive stroke and his vital signs are stable; 6. Not taking any medicines for lower urinary tract dysfunction within 2 weeks; 7. Able to follow the clinical treatment plan understand and sign the subject's informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with urinary dysfunction before stroke; 2. Patients with increased intracranial pressure; 3. Patients with serious underlying diseases; 4. Patients who need a lot of fluids or drugs that affect urination during the intervention; 5. Patients with metal implants in the body; 6. Patients have ears nest implanted; 7. Patients who do not agree to continue the study.

Design outcomes

Primary

MeasureTime frame
Bladder capacity;

Secondary

MeasureTime frame
Residual volume;Frequency of urination;Detrusor pressure;Pelvic floor muscle electromyography;fMRI;

Countries

China

Contacts

Public ContactWei Jiang

The Second Affiliated Hospital, Chongqing Medical University, Chongqing

1456886182@qq.com+86 13808341187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026